Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myositis, Inclusion Body | 44 | 2023 | 145 | 15.590 |
Why?
|
Myositis | 18 | 2023 | 278 | 4.310 |
Why?
|
Dermatomyositis | 19 | 2022 | 266 | 4.160 |
Why?
|
Interferon Type I | 15 | 2022 | 565 | 2.570 |
Why?
|
Muscle, Skeletal | 38 | 2023 | 4984 | 2.390 |
Why?
|
Polymyositis | 10 | 2013 | 77 | 2.240 |
Why?
|
Muscle Fibers, Skeletal | 8 | 2020 | 552 | 1.730 |
Why?
|
5'-Nucleotidase | 6 | 2020 | 164 | 1.680 |
Why?
|
Interferon-beta | 8 | 2017 | 348 | 1.490 |
Why?
|
Lectins, C-Type | 5 | 2022 | 589 | 0.920 |
Why?
|
Neuromuscular Diseases | 6 | 2014 | 262 | 0.870 |
Why?
|
Muscle Proteins | 6 | 2011 | 1165 | 0.820 |
Why?
|
Receptors, Immunologic | 6 | 2022 | 1411 | 0.820 |
Why?
|
Autoantibodies | 8 | 2020 | 2131 | 0.810 |
Why?
|
Muscle Weakness | 6 | 2013 | 415 | 0.790 |
Why?
|
Lichen Planus, Oral | 1 | 2022 | 57 | 0.780 |
Why?
|
Scapula | 2 | 2013 | 176 | 0.740 |
Why?
|
Guillain-Barre Syndrome | 3 | 2014 | 128 | 0.740 |
Why?
|
Leukemia, Large Granular Lymphocytic | 2 | 2020 | 24 | 0.700 |
Why?
|
Autoimmune Diseases | 4 | 2023 | 2260 | 0.690 |
Why?
|
Interferon-alpha | 8 | 2013 | 909 | 0.630 |
Why?
|
Cytokines | 8 | 2019 | 7440 | 0.620 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2022 | 1786 | 0.590 |
Why?
|
Myasthenia Gravis | 2 | 2015 | 218 | 0.580 |
Why?
|
Oligonucleotide Array Sequence Analysis | 16 | 2012 | 3793 | 0.560 |
Why?
|
Follistatin | 1 | 2017 | 138 | 0.540 |
Why?
|
Sarcoplasmic Reticulum | 3 | 2014 | 164 | 0.510 |
Why?
|
Cell Nucleus | 5 | 2014 | 2889 | 0.500 |
Why?
|
Lambert-Eaton Myasthenic Syndrome | 1 | 2015 | 8 | 0.500 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 2 | 2013 | 62 | 0.480 |
Why?
|
Ubiquitins | 3 | 2013 | 367 | 0.480 |
Why?
|
Motor Neuron Disease | 1 | 2015 | 98 | 0.460 |
Why?
|
Immunoglobulin Isotypes | 1 | 2014 | 158 | 0.460 |
Why?
|
Nitrous Oxide | 1 | 2015 | 166 | 0.460 |
Why?
|
Autoantigens | 4 | 2013 | 893 | 0.450 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2015 | 119 | 0.450 |
Why?
|
Median Nerve | 1 | 2014 | 133 | 0.440 |
Why?
|
Vitamin B 12 | 2 | 2015 | 527 | 0.430 |
Why?
|
Zinc | 2 | 2010 | 677 | 0.430 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2023 | 4613 | 0.430 |
Why?
|
Publication Bias | 2 | 2011 | 160 | 0.430 |
Why?
|
Muscles | 2 | 2016 | 1582 | 0.420 |
Why?
|
Plasma Cells | 4 | 2014 | 598 | 0.410 |
Why?
|
Muscular Diseases | 5 | 2010 | 555 | 0.410 |
Why?
|
Ataxia | 1 | 2014 | 307 | 0.390 |
Why?
|
Isoantibodies | 1 | 2016 | 682 | 0.390 |
Why?
|
Dendritic Cells | 5 | 2012 | 2753 | 0.390 |
Why?
|
Carpal Tunnel Syndrome | 2 | 2014 | 304 | 0.390 |
Why?
|
Humans | 105 | 2023 | 768369 | 0.390 |
Why?
|
Myokymia | 1 | 2011 | 11 | 0.390 |
Why?
|
Ribonucleoproteins | 1 | 2014 | 360 | 0.380 |
Why?
|
DEAD-box RNA Helicases | 1 | 2014 | 384 | 0.370 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2011 | 37 | 0.370 |
Why?
|
Fasciitis | 1 | 2012 | 67 | 0.370 |
Why?
|
Gene Expression Profiling | 13 | 2012 | 9508 | 0.360 |
Why?
|
Carboxymethylcellulose Sodium | 1 | 2010 | 38 | 0.360 |
Why?
|
Up-Regulation | 6 | 2019 | 4132 | 0.360 |
Why?
|
Vacuoles | 2 | 2013 | 225 | 0.360 |
Why?
|
Movement Disorders | 1 | 2014 | 464 | 0.350 |
Why?
|
Gene Expression | 7 | 2014 | 7605 | 0.350 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2005 | 614 | 0.340 |
Why?
|
Muscle Cells | 2 | 2012 | 195 | 0.340 |
Why?
|
Proteomics | 4 | 2012 | 3901 | 0.340 |
Why?
|
Sarcomeres | 2 | 2009 | 378 | 0.330 |
Why?
|
Antibodies, Monoclonal | 5 | 2014 | 9261 | 0.330 |
Why?
|
Muscle Fibers, Fast-Twitch | 1 | 2009 | 71 | 0.320 |
Why?
|
Immunologic Factors | 4 | 2020 | 1600 | 0.320 |
Why?
|
Scleroderma, Systemic | 4 | 2014 | 349 | 0.320 |
Why?
|
T-Lymphocytes | 6 | 2020 | 10269 | 0.320 |
Why?
|
Autoimmunity | 3 | 2013 | 1361 | 0.310 |
Why?
|
Antibodies, Neoplasm | 1 | 2009 | 283 | 0.300 |
Why?
|
Nervous System Diseases | 3 | 2004 | 1668 | 0.300 |
Why?
|
Enzymes | 1 | 2009 | 254 | 0.290 |
Why?
|
Gadolinium DTPA | 1 | 2010 | 823 | 0.280 |
Why?
|
Transcriptional Activation | 2 | 2010 | 1751 | 0.280 |
Why?
|
Skin | 4 | 2010 | 4520 | 0.280 |
Why?
|
Microarray Analysis | 2 | 2014 | 752 | 0.270 |
Why?
|
Muscular Dystrophy, Facioscapulohumeral | 1 | 2007 | 48 | 0.270 |
Why?
|
Microdissection | 4 | 2010 | 151 | 0.270 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2009 | 1115 | 0.260 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2007 | 375 | 0.260 |
Why?
|
Cell Differentiation | 4 | 2019 | 11674 | 0.250 |
Why?
|
Neurology | 2 | 2004 | 786 | 0.250 |
Why?
|
Inclusion Bodies | 3 | 2019 | 279 | 0.250 |
Why?
|
Antigens, CD | 1 | 2016 | 4022 | 0.250 |
Why?
|
Immunohistochemistry | 8 | 2014 | 11139 | 0.250 |
Why?
|
Models, Immunological | 1 | 2007 | 516 | 0.250 |
Why?
|
Polyradiculoneuropathy | 2 | 2002 | 65 | 0.240 |
Why?
|
Ventilator Weaning | 1 | 2006 | 170 | 0.240 |
Why?
|
B-Lymphocytes | 4 | 2011 | 4779 | 0.230 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 2 | 2014 | 30 | 0.230 |
Why?
|
DNA-Binding Proteins | 5 | 2014 | 9623 | 0.220 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2014 | 1644 | 0.220 |
Why?
|
Meningioma | 1 | 2012 | 1222 | 0.210 |
Why?
|
Adenosine Triphosphatases | 1 | 2007 | 842 | 0.210 |
Why?
|
Polymers | 1 | 2010 | 1631 | 0.210 |
Why?
|
GTP-Binding Proteins | 4 | 2010 | 947 | 0.210 |
Why?
|
RNA, Messenger | 8 | 2017 | 12813 | 0.200 |
Why?
|
Biopsy | 8 | 2012 | 6816 | 0.200 |
Why?
|
Ultrasonography | 2 | 2021 | 5994 | 0.200 |
Why?
|
Thymoma | 1 | 2004 | 191 | 0.200 |
Why?
|
Publishing | 1 | 2009 | 836 | 0.200 |
Why?
|
Immunity, Innate | 1 | 2014 | 3076 | 0.200 |
Why?
|
Cytosol | 2 | 2017 | 889 | 0.200 |
Why?
|
Mixed Connective Tissue Disease | 1 | 2001 | 32 | 0.190 |
Why?
|
Male | 38 | 2019 | 364761 | 0.190 |
Why?
|
Myeloid Cells | 1 | 2007 | 831 | 0.190 |
Why?
|
Signal Transduction | 7 | 2022 | 23639 | 0.190 |
Why?
|
Copper | 1 | 2004 | 368 | 0.190 |
Why?
|
Thymus Neoplasms | 1 | 2004 | 278 | 0.180 |
Why?
|
Electromyography | 4 | 2016 | 1399 | 0.180 |
Why?
|
Myoblasts | 1 | 2022 | 234 | 0.180 |
Why?
|
Middle Aged | 28 | 2019 | 223406 | 0.180 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2002 | 289 | 0.180 |
Why?
|
Nervous System | 1 | 2004 | 547 | 0.180 |
Why?
|
Data Collection | 1 | 2009 | 3329 | 0.170 |
Why?
|
Hematologic Diseases | 1 | 2004 | 499 | 0.170 |
Why?
|
Receptor, Interferon alpha-beta | 2 | 2010 | 111 | 0.170 |
Why?
|
Artificial Intelligence | 1 | 2014 | 2659 | 0.170 |
Why?
|
Gene Expression Regulation | 9 | 2012 | 11928 | 0.160 |
Why?
|
Mass Spectrometry | 3 | 2013 | 2204 | 0.160 |
Why?
|
tau Proteins | 1 | 2009 | 2130 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 8 | 2022 | 36840 | 0.160 |
Why?
|
Fluorescent Antibody Technique | 3 | 2014 | 2477 | 0.150 |
Why?
|
Amyloid beta-Peptides | 2 | 2009 | 3892 | 0.150 |
Why?
|
Aged | 20 | 2018 | 171514 | 0.150 |
Why?
|
Sjogren's Syndrome | 1 | 2020 | 242 | 0.150 |
Why?
|
Immunoglobulins | 3 | 2014 | 856 | 0.140 |
Why?
|
Immunoblotting | 2 | 2011 | 1650 | 0.140 |
Why?
|
Female | 34 | 2020 | 396926 | 0.140 |
Why?
|
Hereditary Sensory and Motor Neuropathy | 1 | 1996 | 22 | 0.140 |
Why?
|
Respiratory Insufficiency | 1 | 2006 | 1244 | 0.140 |
Why?
|
Larynx | 1 | 2021 | 492 | 0.140 |
Why?
|
Carcinoma, Renal Cell | 1 | 2012 | 3198 | 0.140 |
Why?
|
Neural Conduction | 2 | 2011 | 443 | 0.140 |
Why?
|
Arsenic Poisoning | 1 | 1996 | 55 | 0.140 |
Why?
|
South Australia | 1 | 2016 | 27 | 0.130 |
Why?
|
Adult | 29 | 2020 | 223528 | 0.130 |
Why?
|
Microscopy, Immunoelectron | 2 | 2007 | 317 | 0.130 |
Why?
|
Myelin Proteins | 1 | 1996 | 212 | 0.130 |
Why?
|
Cell Cycle Proteins | 1 | 2007 | 3464 | 0.130 |
Why?
|
Chemokine CXCL10 | 1 | 2017 | 311 | 0.130 |
Why?
|
Databases, Genetic | 3 | 2010 | 1754 | 0.130 |
Why?
|
Trachea | 1 | 2021 | 1095 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 3813 | 0.120 |
Why?
|
Chromatography, Liquid | 2 | 2009 | 998 | 0.120 |
Why?
|
Kidney Neoplasms | 1 | 2012 | 4299 | 0.120 |
Why?
|
Biomedical Research | 1 | 2011 | 3463 | 0.120 |
Why?
|
Lymphocytosis | 1 | 2016 | 121 | 0.120 |
Why?
|
Nuclear Proteins | 2 | 2007 | 5808 | 0.120 |
Why?
|
Diagnosis, Differential | 4 | 2015 | 13025 | 0.120 |
Why?
|
Peripheral Nervous System Diseases | 3 | 1996 | 716 | 0.120 |
Why?
|
Smad2 Protein | 1 | 2014 | 144 | 0.120 |
Why?
|
Smad3 Protein | 1 | 2014 | 166 | 0.120 |
Why?
|
Neoplasms | 1 | 2023 | 22389 | 0.110 |
Why?
|
Antibodies, Blocking | 1 | 2014 | 250 | 0.110 |
Why?
|
Activin Receptors, Type II | 1 | 2014 | 123 | 0.110 |
Why?
|
Demyelinating Diseases | 1 | 1996 | 359 | 0.110 |
Why?
|
Immune System | 2 | 2010 | 801 | 0.110 |
Why?
|
Myofibrils | 1 | 2014 | 143 | 0.110 |
Why?
|
Immunosuppressive Agents | 3 | 2017 | 4213 | 0.110 |
Why?
|
Thigh | 1 | 2014 | 239 | 0.110 |
Why?
|
B-Cell Maturation Antigen | 2 | 2014 | 149 | 0.110 |
Why?
|
Research Design | 1 | 2009 | 6217 | 0.110 |
Why?
|
Down-Regulation | 3 | 2012 | 2942 | 0.110 |
Why?
|
Myopathies, Nemaline | 2 | 2004 | 73 | 0.110 |
Why?
|
Antigen Presentation | 2 | 2010 | 1247 | 0.110 |
Why?
|
Myelitis, Transverse | 1 | 2013 | 40 | 0.110 |
Why?
|
Osteitis Deformans | 1 | 2013 | 54 | 0.110 |
Why?
|
Critical Care | 1 | 2006 | 2717 | 0.100 |
Why?
|
Creatine Kinase | 2 | 2012 | 685 | 0.100 |
Why?
|
Brain Neoplasms | 3 | 2012 | 9177 | 0.100 |
Why?
|
Glycolysis | 2 | 2009 | 838 | 0.100 |
Why?
|
Molecular Weight | 1 | 2014 | 2173 | 0.100 |
Why?
|
Epitope Mapping | 1 | 2013 | 299 | 0.100 |
Why?
|
Antigens, Surface | 2 | 2007 | 1615 | 0.100 |
Why?
|
Homocysteine | 1 | 2015 | 637 | 0.100 |
Why?
|
Point Mutation | 1 | 1996 | 1596 | 0.090 |
Why?
|
Prions | 1 | 2013 | 177 | 0.090 |
Why?
|
Phosphorylation | 2 | 2014 | 8331 | 0.090 |
Why?
|
History, 19th Century | 2 | 2004 | 716 | 0.090 |
Why?
|
Mutant Proteins | 1 | 2013 | 489 | 0.090 |
Why?
|
Muscular Atrophy | 1 | 2014 | 335 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 4582 | 0.090 |
Why?
|
Membrane Glycoproteins | 3 | 2007 | 3710 | 0.090 |
Why?
|
Neuromuscular Agents | 1 | 2012 | 148 | 0.090 |
Why?
|
Immunoprecipitation | 1 | 2013 | 876 | 0.090 |
Why?
|
B-Cell Activating Factor | 1 | 2010 | 116 | 0.090 |
Why?
|
Chelation Therapy | 1 | 2010 | 77 | 0.090 |
Why?
|
Frontotemporal Dementia | 1 | 2013 | 250 | 0.080 |
Why?
|
Animals | 12 | 2019 | 169424 | 0.080 |
Why?
|
Glycogen Storage Disease Type III | 1 | 2009 | 13 | 0.080 |
Why?
|
Leukocytes, Mononuclear | 2 | 2022 | 1852 | 0.080 |
Why?
|
Membrane Proteins | 1 | 2006 | 7895 | 0.080 |
Why?
|
Congo Red | 1 | 2009 | 48 | 0.080 |
Why?
|
Organ Size | 1 | 2014 | 2268 | 0.080 |
Why?
|
Autocrine Communication | 1 | 2010 | 169 | 0.080 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 284 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2001 | 1943 | 0.080 |
Why?
|
Cells, Cultured | 3 | 2019 | 19035 | 0.080 |
Why?
|
Lymphoid Tissue | 1 | 2010 | 445 | 0.080 |
Why?
|
Choristoma | 1 | 2010 | 205 | 0.080 |
Why?
|
Toll-Like Receptor 9 | 1 | 2010 | 199 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 2 | 2009 | 18047 | 0.080 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2010 | 173 | 0.080 |
Why?
|
Calpain | 1 | 2009 | 147 | 0.080 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2010 | 706 | 0.080 |
Why?
|
Syndecan-1 | 2 | 2007 | 163 | 0.080 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 4774 | 0.080 |
Why?
|
Actinin | 1 | 2009 | 165 | 0.080 |
Why?
|
Nuclear Envelope | 1 | 2009 | 164 | 0.080 |
Why?
|
Cluster Analysis | 3 | 2012 | 2730 | 0.070 |
Why?
|
Cell Count | 2 | 2010 | 1834 | 0.070 |
Why?
|
Leukocytes | 2 | 2013 | 2030 | 0.070 |
Why?
|
Germinal Center | 1 | 2010 | 379 | 0.070 |
Why?
|
Biological Assay | 1 | 2010 | 629 | 0.070 |
Why?
|
Lupus Erythematosus, Systemic | 3 | 2011 | 2173 | 0.070 |
Why?
|
RecQ Helicases | 1 | 2007 | 53 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26348 | 0.070 |
Why?
|
Protein Array Analysis | 1 | 2009 | 399 | 0.070 |
Why?
|
Myosin Heavy Chains | 1 | 2009 | 404 | 0.070 |
Why?
|
Cross Reactions | 1 | 2009 | 825 | 0.070 |
Why?
|
Solubility | 1 | 2009 | 1085 | 0.070 |
Why?
|
Antibody Specificity | 1 | 2009 | 1063 | 0.070 |
Why?
|
Mutation | 3 | 2013 | 30235 | 0.070 |
Why?
|
Transcription, Genetic | 3 | 2010 | 7602 | 0.070 |
Why?
|
Cohort Studies | 5 | 2019 | 41782 | 0.070 |
Why?
|
Databases, Protein | 1 | 2009 | 387 | 0.070 |
Why?
|
Cell Lineage | 2 | 2007 | 2575 | 0.070 |
Why?
|
DNA Probes | 2 | 2005 | 542 | 0.070 |
Why?
|
Immunoglobulin Switch Region | 1 | 2007 | 44 | 0.070 |
Why?
|
Neurofilament Proteins | 1 | 2009 | 337 | 0.070 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2007 | 57 | 0.070 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 1734 | 0.070 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2012 | 558 | 0.070 |
Why?
|
Prospective Studies | 4 | 2021 | 54913 | 0.070 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2010 | 467 | 0.070 |
Why?
|
Exercise Test | 1 | 2014 | 2186 | 0.070 |
Why?
|
ROC Curve | 1 | 2014 | 3623 | 0.070 |
Why?
|
Review Literature as Topic | 1 | 2009 | 354 | 0.070 |
Why?
|
Nerve Tissue Proteins | 2 | 2012 | 4417 | 0.070 |
Why?
|
Exodeoxyribonucleases | 1 | 2007 | 191 | 0.070 |
Why?
|
Endopeptidases | 1 | 2010 | 772 | 0.070 |
Why?
|
Syndecans | 1 | 2005 | 75 | 0.070 |
Why?
|
Video Recording | 1 | 2011 | 974 | 0.060 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2007 | 182 | 0.060 |
Why?
|
Aged, 80 and over | 6 | 2014 | 59679 | 0.060 |
Why?
|
Lamin Type A | 1 | 2006 | 189 | 0.060 |
Why?
|
History, 20th Century | 2 | 2004 | 2772 | 0.060 |
Why?
|
B-Lymphocyte Subsets | 1 | 2007 | 240 | 0.060 |
Why?
|
Lasers | 1 | 2010 | 952 | 0.060 |
Why?
|
Dystrophin | 1 | 2006 | 284 | 0.060 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2008 | 660 | 0.060 |
Why?
|
Organ Specificity | 1 | 2010 | 1974 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2010 | 1706 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2022 | 15965 | 0.060 |
Why?
|
Spinal Cord | 2 | 2004 | 1814 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2010 | 977 | 0.060 |
Why?
|
Health Care Costs | 1 | 2018 | 3266 | 0.060 |
Why?
|
Genome | 1 | 2013 | 1750 | 0.060 |
Why?
|
Muscle Contraction | 2 | 2012 | 1208 | 0.060 |
Why?
|
Amyloid | 1 | 2009 | 852 | 0.060 |
Why?
|
Complement Membrane Attack Complex | 1 | 2004 | 105 | 0.060 |
Why?
|
London | 1 | 2004 | 233 | 0.060 |
Why?
|
Atrophy | 1 | 2009 | 1648 | 0.060 |
Why?
|
Rheumatic Diseases | 1 | 2011 | 664 | 0.060 |
Why?
|
Pedigree | 1 | 2012 | 4545 | 0.060 |
Why?
|
Ceruloplasmin | 1 | 2004 | 57 | 0.060 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2020 | 672 | 0.060 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2007 | 545 | 0.060 |
Why?
|
Proteins | 2 | 2010 | 6009 | 0.050 |
Why?
|
Liver | 1 | 2019 | 7575 | 0.050 |
Why?
|
Double-Blind Method | 2 | 2014 | 12450 | 0.050 |
Why?
|
Molecular Biology | 1 | 2007 | 573 | 0.050 |
Why?
|
Microscopy, Electron | 1 | 2006 | 2565 | 0.050 |
Why?
|
Vital Capacity | 1 | 2006 | 984 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2011 | 39429 | 0.050 |
Why?
|
Protein Kinases | 1 | 2010 | 1608 | 0.050 |
Why?
|
Cell Line | 2 | 2014 | 15610 | 0.050 |
Why?
|
Proteoglycans | 1 | 2005 | 807 | 0.050 |
Why?
|
Interleukin-1beta | 1 | 2008 | 1021 | 0.050 |
Why?
|
Kinetics | 1 | 2010 | 6347 | 0.050 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2007 | 733 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2011 | 4362 | 0.050 |
Why?
|
Genomics | 2 | 2012 | 5912 | 0.050 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2013 | 1472 | 0.050 |
Why?
|
Blotting, Western | 1 | 2009 | 5042 | 0.050 |
Why?
|
Artifacts | 1 | 2010 | 1927 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2016 | 22286 | 0.050 |
Why?
|
Tracheostomy | 1 | 2006 | 433 | 0.050 |
Why?
|
Immunotherapy | 3 | 2012 | 4728 | 0.050 |
Why?
|
Palate, Soft | 1 | 2021 | 100 | 0.050 |
Why?
|
Antibodies | 1 | 2009 | 2426 | 0.050 |
Why?
|
Laboratories | 1 | 2005 | 463 | 0.050 |
Why?
|
Alopecia Areata | 1 | 2004 | 130 | 0.050 |
Why?
|
RNA-Binding Proteins | 1 | 2010 | 1885 | 0.050 |
Why?
|
Indoles | 1 | 2009 | 1834 | 0.050 |
Why?
|
Capillaries | 1 | 2004 | 756 | 0.050 |
Why?
|
MicroRNAs | 2 | 2014 | 3806 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8051 | 0.040 |
Why?
|
Cell Movement | 1 | 2012 | 5223 | 0.040 |
Why?
|
Sequence Alignment | 1 | 2005 | 2184 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6087 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2010 | 6527 | 0.040 |
Why?
|
Peripheral Nerves | 1 | 2004 | 492 | 0.040 |
Why?
|
Vaccination | 1 | 2012 | 3433 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2882 | 0.040 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2002 | 271 | 0.040 |
Why?
|
Treatment Failure | 1 | 2006 | 2655 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2910 | 0.040 |
Why?
|
Hand Strength | 1 | 2022 | 465 | 0.040 |
Why?
|
Blood Vessels | 1 | 2005 | 1112 | 0.040 |
Why?
|
Young Adult | 4 | 2015 | 60038 | 0.040 |
Why?
|
Multigene Family | 1 | 2002 | 1081 | 0.040 |
Why?
|
Gene Deletion | 1 | 2007 | 2674 | 0.040 |
Why?
|
Proteome | 1 | 2009 | 1881 | 0.040 |
Why?
|
Uncertainty | 1 | 2004 | 758 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 2 | 2011 | 3762 | 0.040 |
Why?
|
Perforin | 1 | 2019 | 166 | 0.040 |
Why?
|
Prednisone | 1 | 2004 | 1568 | 0.040 |
Why?
|
Prednisolone | 1 | 2020 | 327 | 0.040 |
Why?
|
Inclusion Bodies, Viral | 1 | 2018 | 45 | 0.040 |
Why?
|
Gene Library | 1 | 2001 | 1064 | 0.040 |
Why?
|
Liver Cirrhosis, Biliary | 1 | 2019 | 108 | 0.040 |
Why?
|
Molecular Targeted Therapy | 1 | 2010 | 2834 | 0.040 |
Why?
|
Neutropenia | 1 | 2004 | 892 | 0.040 |
Why?
|
Azathioprine | 1 | 2020 | 354 | 0.040 |
Why?
|
Vasculitis | 1 | 2002 | 524 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4426 | 0.040 |
Why?
|
Granzymes | 1 | 2019 | 278 | 0.040 |
Why?
|
Hepatitis | 1 | 2019 | 228 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2014 | 65408 | 0.040 |
Why?
|
Retrospective Studies | 5 | 2018 | 81835 | 0.040 |
Why?
|
Metabolic Diseases | 1 | 2004 | 685 | 0.040 |
Why?
|
Peptides | 1 | 2009 | 4368 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 3543 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2022 | 1868 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2010 | 4948 | 0.030 |
Why?
|
Graft vs Host Disease | 1 | 2009 | 3042 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 2019 | 865 | 0.030 |
Why?
|
Nystagmus, Pathologic | 1 | 1996 | 104 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 427 | 0.030 |
Why?
|
Models, Genetic | 1 | 2005 | 3442 | 0.030 |
Why?
|
Athetosis | 1 | 1994 | 15 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2022 | 1371 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 3253 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 2005 | 5490 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2014 | 18390 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2007 | 3586 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14725 | 0.030 |
Why?
|
Algorithms | 2 | 2005 | 14157 | 0.030 |
Why?
|
HLA Antigens | 1 | 2020 | 1333 | 0.030 |
Why?
|
Immunoglobulin J-Chains | 1 | 2014 | 26 | 0.030 |
Why?
|
Facial Nerve | 1 | 1996 | 277 | 0.030 |
Why?
|
Chorea | 1 | 1994 | 79 | 0.030 |
Why?
|
Anemia | 1 | 2004 | 1521 | 0.030 |
Why?
|
Mice | 4 | 2014 | 82051 | 0.030 |
Why?
|
Risk | 2 | 2019 | 9642 | 0.030 |
Why?
|
Genes, Dominant | 1 | 1996 | 856 | 0.030 |
Why?
|
Electrophysiology | 1 | 1996 | 1266 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2005 | 5803 | 0.030 |
Why?
|
Haplotypes | 1 | 2020 | 2723 | 0.030 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2014 | 171 | 0.030 |
Why?
|
Methotrexate | 1 | 2020 | 1722 | 0.030 |
Why?
|
Peptide Termination Factors | 1 | 2013 | 56 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2207 | 0.030 |
Why?
|
Linear Models | 1 | 2002 | 5880 | 0.030 |
Why?
|
Chronic Disease | 2 | 2009 | 9379 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2014 | 551 | 0.020 |
Why?
|
Fibrosis | 1 | 2019 | 2076 | 0.020 |
Why?
|
Meningococcal Vaccines | 1 | 2012 | 96 | 0.020 |
Why?
|
Length of Stay | 1 | 2006 | 6521 | 0.020 |
Why?
|
Child, Preschool | 3 | 2021 | 42620 | 0.020 |
Why?
|
Vaccines, Conjugate | 1 | 2012 | 334 | 0.020 |
Why?
|
Software | 1 | 2005 | 4465 | 0.020 |
Why?
|
Hearing Loss, Sensorineural | 1 | 1996 | 783 | 0.020 |
Why?
|
Infant | 2 | 2021 | 36496 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 1996 | 1282 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20763 | 0.020 |
Why?
|
Adolescent | 3 | 2012 | 89163 | 0.020 |
Why?
|
Multiple Sclerosis | 1 | 2004 | 3245 | 0.020 |
Why?
|
Placebos | 1 | 2013 | 1668 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2013 | 13447 | 0.020 |
Why?
|
Child | 4 | 2021 | 80856 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 949 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 895 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2013 | 17637 | 0.020 |
Why?
|
Pain | 1 | 2002 | 5096 | 0.020 |
Why?
|
Phenotype | 2 | 2003 | 16712 | 0.020 |
Why?
|
HeLa Cells | 1 | 2013 | 3091 | 0.020 |
Why?
|
Interleukins | 1 | 2011 | 791 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3790 | 0.020 |
Why?
|
Acute Disease | 1 | 1996 | 7245 | 0.020 |
Why?
|
Blood Proteins | 1 | 2011 | 1183 | 0.020 |
Why?
|
Alzheimer Disease | 2 | 2005 | 8723 | 0.020 |
Why?
|
Immunoglobulin Variable Region | 1 | 2007 | 420 | 0.020 |
Why?
|
Withholding Treatment | 1 | 2010 | 621 | 0.020 |
Why?
|
Necrosis | 1 | 2010 | 1622 | 0.020 |
Why?
|
NF-kappa B | 1 | 2014 | 2491 | 0.020 |
Why?
|
Disease Progression | 1 | 2002 | 13643 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2004 | 9425 | 0.020 |
Why?
|
Prognosis | 1 | 2006 | 30031 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2021 | 26394 | 0.010 |
Why?
|
Exanthema | 1 | 2009 | 504 | 0.010 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2009 | 687 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2004 | 326 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2013 | 1725 | 0.010 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2013 | 1841 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10601 | 0.010 |
Why?
|
RNA | 1 | 2013 | 2728 | 0.010 |
Why?
|
Expressed Sequence Tags | 1 | 2003 | 250 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 8081 | 0.010 |
Why?
|
Antibody Formation | 1 | 2007 | 1393 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15879 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2004 | 13709 | 0.010 |
Why?
|
Medicare | 1 | 2018 | 6880 | 0.010 |
Why?
|
Genome, Human | 1 | 2012 | 4454 | 0.010 |
Why?
|
Information Storage and Retrieval | 1 | 2005 | 823 | 0.010 |
Why?
|
Troponin T | 1 | 2004 | 787 | 0.010 |
Why?
|
Risk Factors | 1 | 2006 | 74915 | 0.010 |
Why?
|
Calcium Signaling | 1 | 2003 | 737 | 0.010 |
Why?
|
Probability | 1 | 2002 | 2483 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2004 | 20232 | 0.010 |
Why?
|
Reference Values | 1 | 2002 | 4941 | 0.010 |
Why?
|
Cell Cycle | 1 | 2003 | 2942 | 0.010 |
Why?
|
Inflammation | 1 | 2014 | 10863 | 0.010 |
Why?
|
Myocardium | 1 | 2007 | 4789 | 0.010 |
Why?
|
Sensation Disorders | 1 | 1994 | 159 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2009 | 3623 | 0.010 |
Why?
|
Regeneration | 1 | 2002 | 1527 | 0.010 |
Why?
|
Proprioception | 1 | 1994 | 134 | 0.010 |
Why?
|
Base Sequence | 1 | 2004 | 12426 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2003 | 2901 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2009 | 5708 | 0.010 |
Why?
|
United States | 1 | 2018 | 73120 | 0.010 |
Why?
|
Genetic Variation | 1 | 2004 | 6607 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2005 | 15459 | 0.000 |
Why?
|
Corpus Striatum | 1 | 1994 | 1238 | 0.000 |
Why?
|
Models, Biological | 1 | 2003 | 9505 | 0.000 |
Why?
|
Transcription Factors | 1 | 2005 | 12176 | 0.000 |
Why?
|
Neural Pathways | 1 | 1994 | 3122 | 0.000 |
Why?
|
Cerebral Cortex | 1 | 1994 | 5827 | 0.000 |
Why?
|